The performance of Black Diamond Therapeutics Inc (BDTX) Stock has improved
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
The Black Diamond Therapeutics Inc (BDTX) Stock expansion path ahead
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
Black Diamond Therapeutics Inc (BDTX) Stock offers help to cash-strapped investors
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
Is it possible to sustain this rally? Black Diamond Therapeutics Inc (BDTX) Stock
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
Does Black Diamond Therapeutics Inc (BDTX) Stock have plenty of room for growth?
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
Analysts Rating: Black Diamond Therapeutics Inc (NASDAQ:BDTX) Stock Won “an Overweight” Rating From Piper Sandler
Piper Sandler raised the price target for the Black Diamond Therapeutics Inc (NASDAQ:BDTX) stock to “an Overweight”. The rating was released on July 14, 2023, according to finviz. We previously noted in another research note published on June 30, 2023 by Stifel that upgraded the stock from a Hold to a Buy with a price […]
